Memantine treatment reduces the expression of the K(+)/Cl(-) cotransporter KCC2 in the hippocampus and cerebral cortex, and attenuates behavioural responses mediated by GABA(A) receptor activation in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/19236854

Download in:

View as

General Info

PMID
19236854